Dynamic changes in NADPH-diaphorase staining reflect activity of nitric oxide synthase: Evidence for a dopaminergic regulation of striatal nitric oxide release
暂无分享,去创建一个
B. Morris | C. S. Simpson | S. Mundell | K. MacEachern | H. Johnston | A. Nolan | H. M. Johnston | Brian J. Morris | A. M. Nolan
[1] R. Lenox,et al. In vivo effects of pentobarbital and halothane anesthesia on levels of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in rat brain regions and pituitary. , 1980, Biochemical pharmacology.
[2] S. Vincent,et al. Striatal neurons containing both somatostatin‐ and avian pancreatic polypeptide (APP)‐like immunoreactivities and NADPH‐diaphorase activity: A light and electron microscopic study , 1983, The Journal of comparative neurology.
[3] M. Ichikawa,et al. Light and electron microscopic demonstration of guanylate cyclase in rat brain , 1983, Brain Research.
[4] M. A. Ariano,et al. Distribution of components of the guanosine 3′,5′-phosphate system in rat caudate-putamen , 1983, Neuroscience.
[5] G. Graveland,et al. Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. , 1985, Science.
[6] S. Moncada,et al. Bioassay of prostacyclin and endothelium‐derived relaxing factor (EDRF) from porcine aortic endothelial cells , 1997, British journal of pharmacology.
[7] J. Hancock,et al. The inhibition by diphenyleneiodonium and its analogues of superoxide generation by macrophages. , 1987, The Biochemical journal.
[8] B. Morris,et al. Dopaminergic regulation of striatal proenkephalin mrna and prodynorphin mrna: Contrasting effects of d1 and d2 antagonists , 1988, Neuroscience.
[9] J. Garthwaite,et al. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain , 1988, Nature.
[10] J. Garthwaite,et al. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. , 1989, European journal of pharmacology.
[11] Richard Graham Knowles,et al. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[12] S. Vincent,et al. Histochemical characterization of neuronal NADPH-diaphorase. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[13] G Maura,et al. Aspartate-releasing nerve terminals in rat striatum possess D-2 dopamine receptors mediating inhibition of release. , 1989, The Journal of pharmacology and experimental therapeutics.
[14] Bruno Giros,et al. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics , 1990, Nature.
[15] C. Altar,et al. Discriminatory roles for D1 and D2 dopamine receptor subtypes in the in vivo control of neostriatal cyclic GMP. , 1990, European journal of pharmacology.
[16] A. Carlsson,et al. Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease , 1990, Trends in Neurosciences.
[17] L. Kerkérian,et al. Cortical Regulation of Striatal Neuropeptide Y (NPY)‐Containing Neurons in the Rat , 1990, The European journal of neuroscience.
[18] A. Graybiel. Neurotransmitters and neuromodulators in the basal ganglia , 1990, Trends in Neurosciences.
[19] D. Sibley,et al. Expression of striatal D1 dopamine receptors coupled to inositol phosphate production and Ca2+ mobilization in Xenopus oocytes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[20] Philip Seeman,et al. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine , 1991, Nature.
[21] S. Hunt,et al. Proenkephalin mRNA levels in rat striatum are increased and decreased, respectively, by selective D2 and D1 dopamine receptor antagonists , 1991, Neuroscience Letters.
[22] P. Conn. Methods in neurosciences , 1991 .
[23] S. Young,et al. Terminal excitability of the corticostriatal pathway. II. Regulation by glutamate receptor stimulation , 1991, Brain Research.
[24] S. Snyder,et al. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase , 1991, Nature.
[25] Susan R. George,et al. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1 , 1991, Nature.
[26] J. Hancock,et al. The use of diphenylene iodonium and its analogues to investigate the role of the NADPH oxidase in the tumoricidal activity of macrophages in vitro. , 1991, Free radical biology & medicine.
[27] S. Vincent,et al. Neuronal NADPH diaphorase is a nitric oxide synthase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[28] S. Snyder,et al. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[29] J. Garthwaite. Glutamate, nitric oxide and cell-cell signalling in the nervous system , 1991, Trends in Neurosciences.
[30] F. Murad,et al. Purification and characterization of a human NO synthase. , 1991, Biochemical and biophysical research communications.
[31] G. Böhme,et al. Possible involvement of nitric oxide in long-term potentiation. , 1991, European journal of pharmacology.
[32] S. Young,et al. Terminal excitability of the corticostrial pathway. I. Regulation by dopamine receptor stimulation , 1991, Brain Research.
[33] C. Nathan,et al. Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs 1 , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[34] J. Garthwaite,et al. NMDA receptor activation in rat hippocampus induces cyclic GMP formation through the l-arginine-nitric oxide pathway , 1991, Neuroscience Letters.
[35] F. Murad,et al. Mapping of neural nitric oxide synthase in the rat suggests frequent co-localization with NADPH diaphorase but not with soluble guanylyl cyclase, and novel paraneural functions for nitrinergic signal transduction. , 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[36] B. Morris. Neuropeptide Y Gene Expression , 1992 .
[37] B. Yamamoto,et al. Dopaminergic Modulation of Glutamate Release in Striatum as Measured by Microdialysis , 1992, Journal of neurochemistry.
[38] D. Okada. Two Pathways of Cyclic GMP Production Through Glutamate Receptor‐Mediated Nitric Oxide Synthesis , 1992, Journal of neurochemistry.
[39] D. Reis,et al. Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[40] M. N. Wallace,et al. Activated astrocytes of the mouse hippocampus contain high levels of NADPH-diaphorase. , 1992, Neuroreport.
[41] P. Klatt,et al. Ca2+/calmodulin-dependent cytochrome c reductase activity of brain nitric oxide synthase. , 1992, The Journal of biological chemistry.
[42] G. Wolf,et al. Nitric oxide synthase in rat brain is predominantly located at neuronal endoplasmic reticulum: an electron microscopic demonstration of NADPH-diaphorase activity , 1992, Neuroscience Letters.
[43] P. Marin,et al. A Nitric Oxide Synthase Activity Selectively Stimulated by NMDA Receptors Depends on Protein Kinase C Activation in Mouse Striatal Neurons , 1992, The European journal of neuroscience.
[44] B. Ziółkowska,et al. The NMDA receptor antagonist MK-801 markedly reduces the induction of c-fos gene by haloperidol in the mouse striatum , 1993, Neuroscience Letters.
[45] Joseph Loscalzo,et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds , 1993, Nature.
[46] R. Mackenzie,et al. Cloning and characterization of a truncated dopamine D1 receptor from goldfish retina: stimulation of cyclic AMP production and calcium mobilization. , 1993, Molecular pharmacology.
[47] P. Marin,et al. Non-classical glutamate receptors, blocked by both NMDA and non-NMDA antagonists, stimulate nitric oxide production in neurons , 1993, Neuropharmacology.
[48] Takahiro Matsumoto,et al. A correlation between soluble brain nitric oxide synthase and NADPH-diaphorase activity is only seen after exposure of the tissue to fixative , 1993, Neuroscience Letters.
[49] Yongxiang Wang,et al. Inhibitory actions of diphenyleneiodonium on endothelium‐dependent vasodilatations in vitro and in vivo , 1993, British journal of pharmacology.
[50] H. Johnston,et al. Coexistence of NADPH diaphorase with GABA, glycine, and acetylcholine in rat spinal cord , 1993, The Journal of comparative neurology.
[51] D. Ingram,et al. The correlation between neuron counts and optical density of NADPH-diaphorase histochemistry in the rat striatum: a quantitative study , 1994, Brain Research.
[52] R. Traub,et al. Spinal cord NADPH-diaphorase histochemical staining but not nitric oxide synthase immunoreactivity increases following carrageenan-produced hindpaw inflammation in the rat , 1994, Brain Research.
[53] H. Schulman,et al. Nitric oxide stimulates Ca2+-independent synaptic vesicle release , 1994, Neuron.
[54] R. Weinberg,et al. Type I nitric oxide synthase fully accounts for nadph-diaphorase in rat striatum, but not cortex , 1994, Neuroscience.
[55] S. D. Meriney,et al. Somatostatin-induced inhibition of neuronal Ca2+ current modulated by cGMP-dependent protein kinase , 1994, Nature.
[56] B. Morris,et al. Phenotypic characterisation of rat striatal neurones in primary culture. , 1994, Tissue & cell.
[57] NADPH diaphorase-positive cells in the brain after status epilepticus. , 1994, Neuroreport.
[58] B. Morris,et al. Modulation of α‐Amino‐3‐Hydroxy‐5‐Methylisoxazole‐4‐Propionic Acid (AMPA) Binding Sites by Nitric Oxide , 1994, Journal of neurochemistry.
[59] E. Kandel,et al. Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation , 1994, Nature.
[60] M. Marletta,et al. Nitric oxide synthase: Aspects concerning structure and catalysis , 1994, Cell.
[61] H. Johnston,et al. NMDA and Nitric Oxide Increase Microtubule‐Associated Protein 2 Gene Expression in Hippocampal Granule Cells , 1994, Journal of neurochemistry.
[62] Yong Liu,et al. Induction of NADPH-diaphorase activity in the hippocampus in a rat model of cerebral ischemia and ischemic tolerance , 1994, Brain Research.
[63] B. Morris,et al. Nitric oxide alters proenkephalin and prodynorphin gene expression in hippocampal granule cells , 1994, Neuroscience.
[64] W. Schmidt,et al. Evidence for bidirectional changes in nitric oxide synthase activity in the rat striatum after excitotoxically (quinolinic acid) induced degeneration , 1995, Neuroscience.
[65] Shigetada Nakanishi,et al. Second-order neurones and receptor mechanisms in visual- and olfactory-information processing , 1995, Trends in Neurosciences.
[66] K. Nozaki,et al. Ultrastructural localization and translocation of nitric oxide synthase in the endothelium of the human cerebral artery , 1995, Brain Research.
[67] B. Morris,et al. Induction of c-fos and zif/268 gene expression in rat striatal neurons, following stimulation of D1-like dopamine receptors, involves protein kinase A and protein kinase C , 1995, Neuroscience.
[68] A. Morton,et al. Correlation of neuronal loss with increased expression of NADPH diaphorase in cultured rat cerebellum and cerebral cortex , 1995, Brain Research.
[69] B. Morris. Stimulation of immediate early gene expression in striatal neurons by nitric oxide. , 1995, The Journal of biological chemistry.
[70] P. Slater,et al. Localization of neuronal and endothelial nitric oxide synthase isoforms in human hippocampus , 1997, Neuroscience.